Galderma Group Ltd header image

Galderma Group Ltd

GALD

Equity

ISIN CH1335392721 / Valor 133539272

SIX Swiss Exchange (2025-11-21)

CHF 147.70-0.94%

Galderma Group Ltd
UMushroom community rating:

4.33 3 votes No rating yet

NegativeNeutralPositive

About company

Galderma Group Ltd is a leading company in the dermatology sector, focusing exclusively on this field for over 40 years. The company specializes in developing, manufacturing, and marketing a wide range of dermatological treatments and solutions. Galderma's product portfolio includes therapeutic dermatology products, dermatological skincare, and injectable aesthetic treatments, catering to a diverse range of skin health needs. With a global presence, the company operates research and development centers and manufacturing facilities strategically located around the world. Galderma is dedicated to advancing the field of dermatology through continuous innovation and science-based solutions, aiming to enhance the quality of life for patients with various skin conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

73.5%1Y

%3Y

%5Y

Performance

35.4%1Y

31.6%3Y

31.6%5Y

Volatility

42904 M

Market cap (USD)

344,628

Daily traded volume (Shares)

100.6 / 98.35

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.33

3 votes

Performance:

4.00

Innovation:

4.00

Society:

3.00

Nature:

2.67

Laura Bischofberger

Switzerland, 12 Jun 2024

New kid on the block, lets see where they go after they IPO.

Hein Sweerts de Landas

Switzerland, 12 Jun 2024

It's the trend, personal beautification. Online: photoshop, real world: Galderma!

Lea Katunaric

Switzerland, 12 Jun 2024

Was never too keen on this type of procedures.

EQUITIES OF THE SAME SECTOR

Straumann Holding Ltd

Straumann Holding Ltd Valor: 117544866

Annual Return

-50%0%+50%

Risk level

110

1.30%CHF 96.58

National Healthcare Corp

National Healthcare Corp Valor: 836282

Annual Return

-50%0%+50%

Risk level

110

2.42%USD 130.44

Maternus-Kliniken AG

Maternus-Kliniken AG Valor: 335800

Annual Return

-50%0%+50%

Risk level

110

-0.94%EUR 1.05

Dyne Therapeutics Inc

Dyne Therapeutics Inc Valor: 56806425

Annual Return

-50%0%+50%

Risk level

110

5.27%USD 21.18

Boiron SA

Boiron SA Valor: 487646

Annual Return

-50%0%+50%

Risk level

110

0.95%EUR 26.60

Baxter International Inc

Baxter International Inc Valor: 911702

Annual Return

-50%0%+50%

Risk level

110

5.11%USD 18.31

COSMO Pharmaceuticals N.V.

COSMO Pharmaceuticals N.V. Valor: 32590356

Annual Return

-50%0%+50%

Risk level

110

-0.45%CHF 67.10

Astrana Health Inc

Astrana Health Inc Valor: 28041888

Annual Return

-50%0%+50%

Risk level

110

10.62%USD 22.50

SCHOTT Pharma AG & Co. KGaA

SCHOTT Pharma AG & Co. KGaA Valor: 128964250

Annual Return

-50%0%+50%

Risk level

110

0.66%EUR 18.44

Coloplast A/S

Coloplast A/S Valor: 20259063

Annual Return

-50%0%+50%

Risk level

110

0.55%DKK 580.20

SIX

FactSet

Clearbit

Logos provided by Clearbit